Web Results

Rosiglitazone - Wikipedia

en.wikipedia.org/wiki/Rosiglitazone

Rosiglitazone (trade name Avandia, GlaxoSmithKline) is an antidiabetic drug in the thiazolidinedione class of drugs. It works as an insulin sensitizer, by binding ...

Rosiglitazone: Indications, Side Effects, Warnings - Drugs.com

www.drugs.com/cdi/rosiglitazone.html

Easy to read patient leaflet for rosiglitazone. Includes indications, proper use, special instructions, precautions, and possible side effects.

Avandia (Rosiglitazone Maleate): Side Effects, Interactions, Warning ...

www.rxlist.com/avandia-drug.htm

Learn about Avandia (Rosiglitazone Maleate) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related ...

rosiglitazone, Avandia: Drug Facts, Side Effects and Dosing

www.medicinenet.com/rosiglitazone/article.htm

Dec 18, 2014 ... Explains the medication rosiglitazone (Avandia), a drug used for the treatment of type II diabetes (when other diabetes drugs have failed) ...

Safety Alerts for Human Medical Products > Rosiglitazone ...

www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm477601.htm

Dec 16, 2015 ... The REMS is no longer necessary to ensure that the benefits of rosiglitazone medicines outweigh their risks.

Rosiglitazone (CAS 122320-73-4) | Cayman Chemical

www.caymanchem.com/product/71740

<sup>1,2</sup> Rosiglitazone (BRL 49653) is a prototypical TZD and has served as a reference compound for this class. <sup>3</sup> Rosiglitazone is a potent and selective PPARγ ...

FDA Lifts Final Regulatory Restrictions on Rosiglitazone - Medscape

www.medscape.com/viewarticle/856056

Dec 16, 2015 ... The FDA pulls the plug on its prior risk evaluation and mitigation strategy for rosiglitazone-containing type 2 diabetes medicines.

Effect of Rosiglitazone on the Risk of Myocardial Infarction and ...

www.nejm.org/doi/full/10.1056/NEJMoa072761

Jun 14, 2007 ... Rosiglitazone is widely used to treat patients with type 2 diabetes mellitus, but its effect on cardiovascular morbidity and mortality has not been ...

Drug Safety and Availability > Rosiglitazone maleate (marketed as ...

www.fda.gov/Drugs/DrugSafety/ucm143349.htm

Apr 8, 2016 ... Rosiglitazone is used along with a diet and exercise program and sometimes with one or more other medications to treat type 2 diabetes ...

Postmarket Drug Safety Information for Patients and Providers ...

www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm226956.htm

Sep 23, 2010 ... FDA Drug Safety Communication: Updated Risk Evaluation and Mitigation Strategy (REMS) to Restrict Access to Rosiglitazone-containing ...

More Info

Rosiglitazone: MedlinePlus Drug Information

medlineplus.gov

Jun 15, 2016 ... Rosiglitazone: learn about side effects, dosage, special precautions, and more on MedlinePlus.

Rosiglitazone - DrugBank

www.drugbank.ca

Like other thiazolidinediones, the mechanism of action of rosiglitazone is by activation of the intracellular receptor class of the peroxisome proliferator- activated ...

rosiglitazone | C18H19N3O3S - PubChem

pubchem.ncbi.nlm.nih.gov

Rosiglitazone is an anti-diabetic drug in the thiazolidinedione class of drugs. It is marketed by the pharmaceutical company GlaxoSmithKline as a stand-alone ...